Argent Biopharma Limited has released a press release.
Successful Research Results for MGC on Glioblastoma
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Phase II Clinical Trial on Patients Diagnosed with COVID-19
- Pause In Trade
- MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
- MGC Pharma COVID-19 Business and Operations Update
- Patients Begin Treatment in Clinical Trial of CogniCann
Later from Argent Biopharma
- MGC Pharma Secures Commitments for $3.5m Placement
- Second Ethics Committee Approval for Phase II COVID-19 Trial
- March Quarterly Activity and Cashflow Report
- Phase II Clinical Trial on COVID-19 Patients Commenced
- Voluntary Suspension
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma